Delivery Order SPE2DB20D9335-SPE2DB22FW3V8
Award Date 5/18/22
Potential Completion Date 5/19/22
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The award is a firm fixed-price delivery order, with no set-aside designation, valued at $7,333.20. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of delivery orders for a comprehensive range of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB program administered by the Defense Logistics Agency (DLA), a defense agency. The $2,444.40 firm fixed-price contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $4,074.00 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $4,074.00, is for the supply of NARCAN 4 MG NASAL SPRAY 2S to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical consumables to the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,580 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the DLA's SPE2DB program. The contract is for the delivery of 4,554,970,111 units of NARCAN 4 mg Nasal Spray, a critical opioid overdose treatment medication, to support the recurring medical supply needs of military health facilities. The firm fixed-price contract, valued at $4,888.80, has an ultimate completion date of September 29, 2021. DMS...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,888.80 fixed-price contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This federal contract award is a delivery order valued at $4,074.00 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,202.72 contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract has a completion date of September 28, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order valued at $7,333.20, with an ultimate completion date of January 6, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...